Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Etty Bitton, Claudine Courey, Pamela Giancola, Vasile Diaconu, Jack Wise & Walter Wittich. (2017) Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface. Clinical and Experimental Optometry 100:6, pages 583-589.
Read now
Read now
Tejaswini Walimbe, Vidya Chelerkar, Purvi Bhagat, Abhijeet Joshi & Atul Raut. (2016) Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma. Clinical Ophthalmology 10, pages 821-827.
Read now
Read now
Yasser Helmy Mohamed, Masafumi Uematsu, Naoko Onizuka, Ryotaro Ueki, Daisuke Inoue, Azusa Fujikawa, Hitoshi Sasaki & Takashi Kitaoka. (2016) Acute Corneal Toxicity of Combined Antiglaucoma Topical Eyedrops. Current Eye Research 41:10, pages 1326-1330.
Read now
Read now
Gábor Holló & Andreas Katsanos. (2015) Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma. Expert Opinion on Drug Safety 14:4, pages 609-617.
Read now
Read now
Purvi Bhagat, Kalyani Sodimalla, Chandrima Paul, Surinder S Pandav, Ganesh V Raman, Rengappa Ramakrishnan, Abhijeet Joshi & Atul Raut. (2014) Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 1241-1252.
Read now
Read now
Soner Demirel, Selim Doganay, Iclal Gurses & Mustafa Iraz. (2013) Toxic–Inflammatory Effects of Prostoglandin Analogs on the Ocular Surface. Ocular Immunology and Inflammation 21:1, pages 13-18.
Read now
Read now
Ahmed Salah Gado & Tamer Ahmed Macky. (2012) First experience with BAK-free travoprost 0.004% in topical glaucoma medication. Clinical Ophthalmology 6, pages 1-4.
Read now
Read now
Stephen C Pflugfelder & Christophe Baudouin. (2011) Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clinical Ophthalmology 5, pages 1575-1583.
Read now
Read now
Maurizio Rolando, Julie Y Crider & Malik Y Kahook. (2011) Ophthalmic preservatives: focus on polyquaternium-1. Expert Opinion on Drug Delivery 8:11, pages 1425-1438.
Read now
Read now
Michael B. Horsley & Teresa C. Chen. (2011) The Use of Prostaglandin Analogs in the Uveitic Patient. Seminars in Ophthalmology 26:4-5, pages 285-289.
Read now
Read now
William C. Stewart, Jeanette A. Stewart & Lindsay A. Nelson. (2011) Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma. Current Eye Research 36:5, pages 391-398.
Read now
Read now
Abayomi B Ogundele, Guangming Li & Joel J Ellis. (2010) Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits. Clinical Ophthalmology 4, pages 77-80.
Read now
Read now
Jordana K Schmier & David W Covert. (2010) First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results. Clinical Ophthalmology 4, pages 437-445.
Read now
Read now
Abayomi B Ogundele & Mark C Jasek. (2010) Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits. Clinical Ophthalmology 4, pages 1447-1450.
Read now
Read now
Gregory Katz, Clark L Springs, E Randy Craven & Michela Montecchi-Palmer. (2010) Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost. Clinical Ophthalmology 4, pages 1253-1261.
Read now
Read now
Michael J Miyashiro, Samuel C Lo, Jeanette A Stewart & William C Stewart. (2010) Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients. Clinical Ophthalmology 4, pages 1355-1359.
Read now
Read now
Tao Bai, Jianfeng Huang & Wei Wang. (2010) Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface. Cutaneous and Ocular Toxicology 29:4, pages 247-253.
Read now
Read now
Cristiana Valente & Michele Iester. (2010) Impact of glaucoma medication on ocular tissue. Expert Review of Ophthalmology 5:3, pages 405-412.
Read now
Read now
Jordana K Schmier, David W Covert & Alan L Robin. (2009) First-year treatment costs among new initiators of topical prostaglandin analogs. Clinical Ophthalmology 3, pages 637-644.
Read now
Read now
Articles from other publishers (3)
Yuri Tsugeno, Tatsuya Sato, Megumi Watanabe, Masato Furuhashi, Araya Umetsu, Yosuke Ida, Fumihito Hikage & Hiroshi Ohguro. (2022) Benzalkonium Chloride, Even at Low Concentrations, Deteriorates Intracellular Metabolic Capacity in Human Conjunctival Fibroblasts. Biomedicines 10:9, pages 2315.
Crossref
Crossref
Jose Francisco Ortega-Santana. (2013) Tolerancia y Efectividad de los Análogos de Prostaglandinas en Pacientes Glaucomatosos. Highlights of Ophthalmology 41:3ESP, pages 22-26.
Crossref
Crossref
Jose Francisco Ortega-Santana. (2013) Tolerance and Effectivity of Prostaglandin Analogues in Glaucoma Patients. Highlights of Ophthalmology 41:3ENG, pages 19-22.
Crossref
Crossref